Pharmacodynamics Flashcards

1
Q

how do most drugs produce their effect

A

by binding to protein molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the only important exception to protein being the receptor for drugs

A

DNA (sometimes drugs bind to it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

two types of ion channels

A

voltage gated channels and ligand gated ion channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe voltage gated ion channel

A

conductance is regulated by changes in the membrane potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe ligand gated ion channel

A

conductance is regulated by ligands such as GABA, Ca2+, and etc binding to the channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

example of voltage gated ion channel drug and how it works

A

local anesthetics which block voltage gated sodium channels from transmitting pain information from the periphery to the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

example of ligand gated ion channel drug

A

benzos which bind to GABA receptors thereby enhancing the ability of GABA to open chloride channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does cAMP hormone mediate

A
  • mobilization of stored energy
  • increases rate and contraction force of the heart muscle
  • relaxation of smooth muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what degrades cAMP and what is cAMP degraded to

A

cAMP is degrades to 5’AMP by phosphodiesterases (PDE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

big difference between IP3 and DAG

A

IP3 releases Ca from ER while DAG alongside Ca activates protein kinase C (PKC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of ligand regulated transmembrane enzyme

A

tyrosine kinase, serine/threonine kinase, guanylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examples of tyrosine kinases

A

insulin receptor, epidermal growth factor receptor (EGFR), platelet derived growth factor (PDGFR), nerve growth factor receptor (NGFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do cytokine receptors respond to

A

growth hormone, prolactin, erythropoietin, and interferons

PIGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does the cytokine receptor bind to

A

intracellular tyrosine kinase, from the Janus-kinase (JAK) family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

JAK then phosphorylates another set of proteins referred to as

A

STAT (signal transducers and activators of transcription) –> pathway is referred to as JAK/STAT pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are statins

A

competitive inhibitors of HMG-CoA reductase, the enzyme that catalyzes the first step of cholesterol biosynthesis

17
Q

what is the result/effect of using statin

A

it decreases intracellular cholesterol hence causing an up-regulation of LDL receptors in hepatocytes (in order to increase the intracellular cholesterol) and this leads to increased clearance of LDL from the blood

18
Q

what are structural proteins

A

structures such as tubulin that are important targets for anti neoplastic drugs

19
Q

what type of drugs cause irreversible competitive antagonism

A

those that have reactive groups hence can form covalent bonds with the receptors

20
Q

examples of drugs that are irreversible competitive antagonist

A
  • phenoxybenzamine (alpha adrenoreceptor blocker)

- aspirin, omeprazole, MAO inhibitors which are irreversible enzyme inhibitors

21
Q

effect of a drug gradually diminishing when giving continuously or repeatedly and occurs within course of few minutes is described as

A

desensitization or tachyphylaxis

22
Q

gradual decrease in responsiveness to a drug and taking days to weeks to develop is described as

A

tolerance

23
Q

loss of therapeutic efficacy

A

refractoriness